Suche

Origenis Presents at Sportfire Conference

May 16, 2006

Origenis presents its proprietary multiparametric process for Drug Design, Synthesis and Characterisation at the Sportfire User Conference.

Ähnliche Beiträge

London, UK – OncoBone Ventures Ltd, based in the UK, and Origenis GmbH, headquartered in Planegg, Germany, have signed a Framework Agreement

Die Origenis nutzt ihre AI-Technologieplattform, um hochoptimierte Wirkstoffe für neurodegenerative, neuroonkologische und...

Plattform Life Sciences Interview with Dr Michael Thormann, CEO, Origenis Together with the investor Kleiner Perkins, Origenis GmbH...